Connor, Clark & Lunn Investment Management (CC&L)’s Aurinia Pharmaceuticals AUPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.51M | Sell |
650,191
-96,038
| -13% | -$813K | 0.02% | 547 |
|
|
2025
Q1 | $6M | Buy |
746,229
+189,775
| +34% | +$1.53M | 0.03% | 459 |
|
|
2024
Q4 | $5M | Buy |
556,454
+102,195
| +22% | +$918K | 0.02% | 481 |
|
|
2024
Q3 | $3.33M | Buy |
+454,259
| New | +$3.33M | 0.02% | 542 |
|
|
2021
Q3 | – | Sell |
-367,000
| Closed | -$4.76M | – | 1031 |
|
|
2021
Q2 | $4.76M | Sell |
367,000
-68,912
| -16% | -$893K | 0.02% | 368 |
|
|
2021
Q1 | $5.67M | Sell |
435,912
-1,564,060
| -78% | -$20.3M | 0.03% | 328 |
|
|
2020
Q4 | $27.6M | Buy |
1,999,972
+379,280
| +23% | +$5.23M | 0.16% | 118 |
|
|
2020
Q3 | $23.9M | Buy |
1,620,692
+166,792
| +11% | +$2.46M | 0.16% | 121 |
|
|
2020
Q2 | $23.6M | Buy |
1,453,900
+376,330
| +35% | +$6.11M | 0.17% | 108 |
|
|
2020
Q1 | $15.7M | Buy |
+1,077,570
| New | +$15.7M | 0.14% | 123 |
|